Summit Therapeutics Inc. Quarterly Return On Equity in % from Q4 2020 to Q2 2024

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
Summit Therapeutics Inc. quarterly/annual Return On Equity history and growth rate from Q4 2020 to Q2 2024.
  • Summit Therapeutics Inc. Return On Equity for the quarter ending June 30, 2024 was -155 %, a 66.7% increase year-over-year.
  • Summit Therapeutics Inc. annual Return On Equity for 2023 was -572 %, a 582% decline from 2022.
  • Summit Therapeutics Inc. annual Return On Equity for 2022 was -83.9 %, a 12.6% increase from 2021.
  • Summit Therapeutics Inc. annual Return On Equity for 2021 was -95.9 %, a 9.23% decline from 2020.
Return On Equity, Quarterly (%)
Return On Equity, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Start Date End Date
Q2 2024 -155 +311 +66.7% Apr 1, 2024 Jun 30, 2024
Q1 2024 -136 +403 +74.8% Jan 1, 2024 Mar 31, 2024
Q4 2023 -572 -488 -582% Oct 1, 2023 Dec 31, 2023
Q3 2023 -499 -395 -378% Jul 1, 2023 Sep 30, 2023
Q2 2023 -466 -353 -314% Apr 1, 2023 Jun 30, 2023
Q1 2023 -539 -439 -439% Jan 1, 2023 Mar 31, 2023
Q4 2022 -83.9 +12 +12.6% Oct 1, 2022 Dec 31, 2022
Q3 2022 -104 -22.2 -27% Jul 1, 2022 Sep 30, 2022
Q2 2022 -113 -15.7 -16.2% Apr 1, 2022 Jun 30, 2022
Q1 2022 -100 +8.39 +7.73% Jan 1, 2022 Mar 31, 2022
Q4 2021 -95.9 -8.11 -9.23% Oct 1, 2021 Dec 31, 2021
Q3 2021 -82.1 Jul 1, 2021 Sep 30, 2021
Q2 2021 -97 Apr 1, 2021 Jun 30, 2021
Q1 2021 -109 Jan 1, 2021 Mar 31, 2021
Q4 2020 -87.8 Oct 1, 2020 Dec 31, 2020
* An asterisk sign (*) next to the value indicates that the value is likely invalid.